Patients with diabetes who utilize GLP-1 RAs for 6 months or longer are twice as likely to develop neovascular age-related macular degeneration.

Novo Nordisk and Eli Lilly are currently the major players in the GLP-1RA space, but opportunity remains for new entrants. 7.4 Where Are GLP-1RAs Expected to Position in the Future Chronic Kidney ...

Compared with nonuse, GLP-1RA and thiazolidinedione combination therapy reduced risks for all-cause and cardiovascular mortality in type 2 diabetes. The combination of a glucagon-like peptide 1 ...

This retrospective study suggests there is a cardioprotective effect of GLP-1RA compared to DPP4i in hard ... confounding and lacked data on the dose of GLP-1 RA taken by each person.

A new study links two widely prescribed diabetes drugs to a 33–43% lower risk of Alzheimer’s and related dementias, offering hope for repurposing existing treatments to tackle one of aging’s ...

Researchers found that by December 2023, more than 1 in 3 of the medications being started for type 2 diabetes treatment were GLP-1RA-based medications. When it comes to managing weight loss and ...

Or one might need a unique formulation (e.g., liquid dosing for a patient that ... after eating. GLP-1 receptor agonist drugs (GLP-1RA) mimic what GLP-1 does. In other words, they lend naturally ...

17 Of those, 75 consecutive patients received as a second‐line treatment after metformin, basal insulin, with a total daily dose ... 40 in GLP‐1RA+SGLT‐2i group) were finally included in the analysis.

The rates of depression were similar for the GLP-1RA group and sodium-glucose cotransporter-2 inhibitor (SGLT2i) group. However, compared to participants taking dipeptidyl peptidase-4 inhibitors ...

The growing popularity of GLP-1 agonists for weight management has sparked a surge in alternative dosing methods, particularly microdosing of Ozempic. This emerging practice involves intentionally ...

New GLP-1RA weight loss drugs like Like Ozempic and Wegovy have become extremely popular in recent months but researchers continue to analyze their health effects, both good and bad. Among the ...